S&P 500
7,226.20
+0.01%
Dow Jones
49,494.60
-0.62%
Nasdaq 100
27,685.40
+0.66%
Russell 2000
2,804.78
-0.02%
FTSE 100
10,364.50
0.00%
Nikkei 225
59,260.50
-0.78%

Investing

BDSX logo Biodesix : BDSX

BDSX

Stock Data

$11.08

Change up

$0.10 (0.91%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DIAGNOSTICS & RESEARCH

Biodesix Inc is a Boulder, Colorado-based company specializing in diagnostic solutions, particularly for lung cancer. It offers a range of blood-based tests, such as Nodify XL2 and Nodify CDT, part of its Nodify Lung Nodule Risk Assessment strategy, designed to evaluate lung cancer risk and assist in treatment decisions. The company also provides GeneStrat ddPCR, VeriStrat, and GeneStrat NGS tests for lung cancer diagnosis, focusing on tumor mutations and immune system status. Additionally, Biodesix collaborates with Bio-Rad Laboratories to offer COVID-19 testing solutions, including the Bio-Rad SARS-CoV-2 ddPCR test. It also engages in the discovery, development, and commercialization of companion diagnostics for biopharmaceutical companies.

All Biodesix Articles

1 Article